Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

Launched by ST. LOUIS UNIVERSITY · Jun 25, 2019

Keywords

ClinConnect Summary

The Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER) is a clinical trial that is studying a condition called vertebral artery stenosis, which can lead to strokes. This trial is looking at patients who have had a stroke related to problems in the back part of the brain and have been found to have narrowing or other issues in the vertebral arteries. The goal is to gather information about how these patients are treated and the outcomes of those treatments.

To participate in this study, individuals must be between 18 and 90 years old and have experienced a specific type of stroke. They also need to have been diagnosed with significant narrowing (more than 50%) in their vertebral arteries. However, certain people cannot join, such as pregnant women or those with severe kidney problems. If you’re eligible, you can expect to be part of a registry that collects important health information over time, helping doctors learn more about the best ways to treat this condition and improve patient care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients between 18 and 90 years of age
• • 2. Patient has experienced a posterior circulation ischemic event
• • 3. Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis).
• • 4. Patient has \>50% stenosis on the side being targeted for therapy
• Exclusion Criteria:
• • 1. Pregnant women
• • 2. Contrast Indication to the use of anti-platelet drugs
• • 3. There is tandem vertebral or basilar artery stenosis
• • 4. The serum creatinin is \>2.5
• • 5. Baseline modified Rankin score is \>3
• • 6. \< 5 years life expectancy